Novel solid self-nanoemulsifying drug delivery system (S-SNEDDS) for oral delivery of olmesartan medoxomil: Design, formulation, pharmacokinetic and bioavailability evaluation

Pharmaceutics

Volumn 8, Issue 3, 2016, Pages

  Nasr, Ali ^a   Gardouh, Ahmed ^b   Ghorab, Mamdouh ^b  

^a SINAI UNIVERSITY   (Egypt)

^b Suez Canal University   (Egypt)

Author keywords

Aerosil 200; Capryol 90; Cremophor RH40; Olmesartan; Solid self nanoemulsifying drug delivery system (S SNEDDS); Spray drying; Transcutol HP

Indexed keywords

CAPRYOL; COSURFACTANT; CREMOPHOR; DIETHYLENE GLYCOL MONOETHYL ETHER; DRUG CARRIER; NANOPARTICLE; OLMESARTAN; SURFACTANT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DIFFERENTIAL SCANNING CALORIMETRY; DRUG ANALYSIS; DRUG BIOAVAILABILITY; DRUG CONCENTRATION; DRUG DELIVERY SYSTEM; DRUG DOSAGE FORM COMPARISON; DRUG FORMULATION; DRUG RELEASE; DRUG SOLUBILITY; EMULSION; FLOW; IN VITRO STUDY; NANOEMULSION; NONHUMAN; PARTICLE SIZE; PHASE SEPARATION; RAT; SCANNING ELECTRON MICROSCOPY; SPRAY DRYING; SURFACE PROPERTY; THERMOGRAPHY; TRANSMISSION ELECTRON MICROSCOPY;

EID: 84979211586     PISSN: None     EISSN: 19994923     Source Type: Journal    
DOI: 10.3390/pharmaceutics8030020     Document Type: Article

References (66)

1. Desai, P.; Date, A.; Patravale, B. Overcoming poor oral bioavailability using nanoparticle formulations—Opportunities and limitations. Drug Discov. Today 2012, 9, 87–95. [CrossRef] [PubMed]
2. Wang, Z.; Sun, J.; Wang, Y.; Liu, X.; Liu, Y.; Fu, Q. Preparation and in-vitro/in-vivo evaluation of solid self-emulsifying nitrendipine pellets. Int. J. Pharm. 2010, 383, 1–6. [CrossRef] [PubMed]
3. Pathak, K.; Raghuvanshi, S. Oral bioavailability: Issues and solutions via nanoformulations. Clin. Pharmacokinet. 2015, 54, 325–357. [CrossRef] [PubMed]
4. Robertis, S.; Bonferoni, M.; Elviri, L.; Sandri, G.; Caramella, C.; Bettini, R. Advances in oral controlled drug delivery: The role of drug-polymer and interpolymer non-covalent interactions. Expert Opin. Drug Deliv. 2015, 12, 441–453. [CrossRef] [PubMed]
5. Shafiq, S.; Shakeel, F.; Talegaonkar, S.; Ahmad, F.; Khar, R.; Ali, M. Development and bioavailability assessment of ramipril nanoemulsion formulation. Eur. J. Pharm. Biopharm. 2007, 66, 227–243. [CrossRef] [PubMed]
6. Shen, H.; Zhong, M. Preparation and evaluation of self-microemulsifying drug delivery systems (SMEDDS) containing atorvastatin. J. Pharm. Pharmacol. 2006, 58, 1183–1191. [CrossRef] [PubMed]
7. Hiral, A.; Ami, Y.; Ramesh, B.; Jalpa, S.; Tank, H. Self-nano emulsifying drug delivery system (SNEDDS): Future aspects. Asian J. Pharm. Res. 2013, 3, 21–27.
8. Iosio, T.; Voinovich, D.; Grassi, M.; Pinto, J.; Perissutti, B.; Zacchigna, M. Bi-layered self-emulsifying pellets prepared by co-extrusion and spheronization: Influence of formulation variables and preliminary study on the in vivo absorption. Eur. J. Pharm. Biopharm. 2008, 69, 686–697. [CrossRef] [PubMed]
9. Yi, T.; Wan, J.; Xu, H.; Yang, X. A new solid self-microemulsifying formulation prepared by spray-drying to improve the oral bioavailability of poorly water soluble drugs. Eur. J. Pharm. Biopharm. 2008, 70, 439–444. [CrossRef] [PubMed]
10. Tang, B.; Cheng, G.; Jian, G.; Cai, X. Development of solid self-emulsifying drug delivery systems: Preparation techniques and dosage forms. Drug Discov. Today. 2008, 13, 606–612. [CrossRef] [PubMed]
11. Chen, Y.; Li, G.; Wu, X.; Chen, Z.; Hang, J.; Qin, B. Self-microemulsifying drug delivery system (SMEDDS) of Vinpocetine: Formulation, development and in vivo assessment. Biol. Pharm. Bull. 2008, 31, 118–125. [CrossRef] [PubMed]
12. Kang, B.; Lee, J.; Chon, S. Development of selfmicroemulsifying drug delivery systems (SMEDDS) for oral bioavailability enhancement of simvastatin in beagle dogs. Int. J. Pharm. 2004, 274, 65–73. [CrossRef] [PubMed]
13. Wang, L.; Dong, J.; Chen, J.; Eastoe, J.; Li, X. Design and optimization of a new self-nanoemulsifying drug delivery system. J. Colloid Interface Sci. 2009, 330, 443–448. [CrossRef] [PubMed]
14. Ishida, M.; Tawa, R.; Shibata, N.; Takada, K. Oral solid gentamicin preparation using emulsifier and adsorbent. J. Control. Release 2005, 105, 23–31.
15. Nakagomi, R.; Nakai, D.; Kawai, K.; Yoshigae, Y.; Tokui, T.; Abe, T.; Ikeda, T. Hepatobiliary transport of olmesartan, A novel angiotensin II blocker. Drug Metab. Dispos. 2006, 34, 862–869. [CrossRef] [PubMed]
16. Dixit, R.; Nagarsenker, M. Design, optimization and evaluation of self-nanoemulsifying granules of ezetimibe. Eur. J. Pharm. Sci. 2008, 35, 92–183. [CrossRef] [PubMed]
17. Srinivas, C.; Sagar, S. Enhancing the bioavailability of simvastatin using micro emulsion drug delivery system. Asian J. Pharm. Clin. Res. 2012, 5, 134–139.
18. Date, A.; Nagarsenker, M. Design and evaluationof self-nanoemulsifying drug delivery systems (SNEDDS) for cefpodoxime proxetil. Int. J. Pharm. 2007, 329, 166–172. [CrossRef] [PubMed]
19. Patel, A.; Vavia, P. Preparation and in vivo evaluation of SMEDDS (self-microemulsifying drug delivery system) containing fenofibrate. AAPS J. 2007, 9, 344–352. [CrossRef] [PubMed]
20. Divyakumar, B.; Priyanka, B.; Kiran, B. Formulation and evaluation of self microemulsifying drug delivery system of low solubility drug for enhanced solubility and dissolution. Asian J. Biomed. Pharm. Sci. 2012, 2, 7–14.
21. Atef, E.; Belmonte, A. Formulation, in-vitro and in-vivo characterization of Phenytoin self-emulsifying drug delivery system. Eur. J. Pharm. Sci. 2008, 35, 257–263. [CrossRef] [PubMed]
22. Ehab, I.; Saleh, A.; Ahmed, M.; Mansoor, A. Preparation and in-vitro characterization of self-nanoemulsified drug delivery system (SNEDDS) of all-trans-retinol acetate. Int. J. Pharm. 2004, 285, 109–119.
23. Chopade, V.; Chaudhari, P. Development and evaluation of self emulsifying drug delivery system for lornoxicam. Int. J. Res. Dev. Pharm. Life Sci. 2013, 2, 531–537.
24. Nekkanti, V.; Karatgi, P.; Prabhu, R.; Pillai, R. Solid self-microemulsifying formulation for candesartan cilexetil. AAPS PharmSciTech 2010, 11, 9–17. [CrossRef] [PubMed]
25. Khoo, S.; Humberstone, A.; Porter, C.; Edwards, G.; Charman, W. Formulation, design and bioavailability assessment of lipidic self-emulsifying formulations of halofantrine. Int. J. Pharm. 1998, 167, 155–164. [CrossRef]
26. Balakrishnan, P.; Lee, B.; Oh, D.; Kim, J.; Hong, M.; Jee, J.P.; Kim, J.A.; Yoo, B.; Woo, J.; Yong, C. et al. Enhanced oral bioavailability of coenzyme Q10 by a novel solid self-emulsifying drug delivery system. Int. J. Pharm. 2009, 374, 66–72. [CrossRef] [PubMed]
27. Ghosh, P.; Majithiya, R.; Umrethia, M.; Murthy, S. Design and development of microemulsion drug delivery system of acyclovir for improvement of oral bioavailability. AAPS PharmSciTech 2006, 7, 172–177. [CrossRef] [PubMed]
28. Balakrishnan, P.; Lee, J.; Oh, D. Enhanced oral bioavailability of dexibuprofen by a novel solid self-emulsifying drug delivery system (SEDDS). Eur. J. Pharm. Biopharm. 2009, 72, 539–545. [CrossRef] [PubMed]
29. Zakia, B.; Suyang, Z.; Wenli, Z.; Junlin, W. Formulation, development and bioavailability evaluation of a self-nanoemulsifying drug delivery system (SNEDDS) of Atorvastatin calcium. Int. J. Pharm. 2013, 29, 1103–1113.
30. Arpan, C.; Vineetkumar, P.; Manish, N.; Kamala, V.; Chamanlal, S. A novel lipid-based oral drug delivery system of Nevirapine. Int. J. PharmTech Res. 2011, 3, 1159–1168.
31. Odeberg, J.; Kaufmann, P.; Kroon, K.; Hoglund, P. Lipid drug delivery and rational formulation design for lipophilic drugs with low oral bioavailability, applied to Cyclosporine. Eur. J. Pharm. Sci. 2003, 20, 375–382. [CrossRef] [PubMed]
32. Alaa, A.; Maha, A.; Amal, A.; Ghada, H. Preparation and in vitro evaluation of self-nanoemulsifying drug delivery systems (SNEDDS) containing Clotrimazole. Drug Discov. Ther. 2010, 4, 373–379.
33. Hussein, A. Preparation and evaluation of liquid and solid self-microemulsifying drug delivery system of mebendazole. Iraqi J. Pharm. Sci. 2014, 23, 89–100.
34. Dong, Y.; Jung, A.; Kyung, K.; Bong, K.; Chul, S.; Han, G. Enhanced oral bioavailability of Curcumin via a solid lipid-based self-emulsifying drug delivery system using a spray-drying technique. Biol. Pharm. Bull. 2011, 34, 1179–1186.
35. Sarwar, B.; Katare, O.; Sumant, S.; Singh, B. Solid self-nanoemulsifying systems of olmesartan medoxomil: Formulation development, micromeritic characterization, in vitro and in vivo evaluation. Powder Technol. 2016, 294, 93–104
36. Bhagwat, A.; D’Souza, I. Formulation and evaluation of solid SMEDDS using Aerosil 200 as solid carrier. Int. Curr. Pharm. J. 2012, 12, 414–419.
37. Surender, R.; Mahalaxmi, R.; Srinivas, P.; Deepak, K.; Kumar, A.; Sneh, P. Self-emulsifying systems of Aceclofenac by extrusion/Spheronization: Formulation and evaluation. J. Chem. Pharm. Res. 2011, 3, 280–289.
38. Reddy, M.; Rehana, T.; Ramakrishna, S.; Chowdary, K.; Prakash, V. Cyclodextrin complexes of celecoxib: Molecular-modeling, characterization, and dissolution studies. AAPS PharmSciTech 2004, 6, 68–76. [CrossRef] [PubMed]
39. Tang, J. Self-Emulsifying drug delivery systems: Strategy for improving oral delivery of poorly soluble drugs. Curr. Drug Ther. 2007, 2, 85–93. [CrossRef]
40. Shailesh, T.; Harsh, A.; Chhaganbhai, N. Preparation and characterization of self microemulsifying drug delivery system of olmesartan medoxomil for bioavailability improvement. J. Pharm. 2013, 2013, 1–9.
41. Naseem, A.; Sushama, T.; Roop, K.; Manu, J. Self-nanoemulsifying lipid carrier system for enhancement of oral bioavailability of Etoposide by P-Glycoprotein modulation: In-vitro cell line and in-vivo pharmacokinetic investigation. J. Biomed. Nanotechnol. 2013, 9, 1216–1229.
42. Humberstone, A.; Charman, W. Lipid based vehicles for oral delivery of poorly water soluble drugs. Adv. Drug Deliv. Rev. 2008, 25, 103–128. [CrossRef]
43. Charman, S.; Charman, W.; Rogge, M.; Wilson, T.; Dutko, F.; Pouton, C. Self-emulsifying drug delivery systems: Formulation and biopharmaceutical evaluation of an investigational lipophilic compound. Pharm. Res. 1992, 9, 87–93. [CrossRef] [PubMed]
44. Azeem, A.; Rizwan, M.; Ahmad, F.; Iqbal, Z.; Khar, R.; Aqil, M.; Talegaonkar, S. Nanoemulsion components screening and selection: A technical note. AAPS PharmSciTech. 2009, 10, 69–76. [CrossRef] [PubMed]
45. Elnaggar, Y.; El-Massik, M.; Abdallah, Y. Self-nanoemulsifying drug delivery systems of Tamoxifen citrate: Design and Optimization. Int. J. Pharm. 2009, 380, 133–141. [CrossRef] [PubMed]
46. Anuradha, S.; Pratikkumar, A.; Darshana, H. Peppermint oil based drug delivery system of aceclofenac with improved anti-inflammatory activity and reduced Ulcerogenecity. Int. J. Pharm. Biosci. Technol. 2013, 1, 89–101.
47. Farinato, R.; Rowell, R. Optical properties of emulsions. In Encyclopedia of Emulsion Technology; Marcel Dekker: New York, NY, USA, 2000; Volume 1, pp. 439–479.
48. Lawrence, M. Microemulsions as drug delivery vehicles. Curr. Opin. Colloid Interface Sci. 1996, 1, 826–832. [CrossRef]
49. Chen, M. Lipid excipients and delivery systems for pharmaceutical development: A regulatory perspective. Adv. Drug Deliv. Rev. 2008, 60, 768–777. [CrossRef] [PubMed]
50. Pouton, C. Lipid formulations for oral administration of drugs: Non-emulsifying, self-emulsifying and self-microemulsifying drug delivery systems. Eur. J. Pharm. Sci. 2000, 11, 93–98. [CrossRef]
51. Spernath, A.; Yaghmur, A.; Aserin, A.; Hoffman, R.; Garti, N. Food-grade microemulsions based on nonionic emulsifiers: Media to enhance Lycopene solubilization. J. Agric. Food Chem. 2002, 50, 6917–6922. [CrossRef] [PubMed]
52. Ashok, K.; Kuldeep, S.; Murugesh, K.; Sriram, R.; Ramesh, M. Formulation and development of an Albendazole self-emulsifying drug delivery system (SEDDS) with enhanced systemic exposure. Acta Pharm. 2012, 62, 563–580.
53. Lia, P.; Ghosh, A.; Wagner, R.; Krill, S.; Joshi, Y. Effect of combined use of nonionic surfactant on formation of oil-in-water microemulsions. Int. J. Pharm. 2005, 288, 27–34. [CrossRef] [PubMed]
54. Kallakunta, V.; Bandari, S.; Jukanti, R.; Veerareddy, P. Formulation and evaluation of oral self-emulsifying powder of lercanidipine hydrochloride. Powder Technol. 2012, 221, 375–382. [CrossRef]
55. Sharma, B.; Sharma, A.; Arora, S.; Gupta, S.; Bishnoi, M. Formulation, optimization and evaluation of novel nanoemulsion formulations for transdermal potential of Celecoxib. Acta Pharm. 2007, 57, 315–323.
56. Patel, P.; Patel, M.; Patel, k.; Patel, N. Design and development of self-microemulsifying drug delivery system of Clopidogrel bisulphate. Int. J. Pharm. Ind. 2013, 1, 539–553.
57. Maulik, J.; Natvarlal, M.; Ritesh, B.; Rakesh, P. Self-microemulsion of Lovastatin. Asian J. Pharm. Sci. 2010, 5, 266–275.
58. Wu, X.; Xu, J.; Huang, X.; Wen, C. Self-microemulsifying drug delivery system improves curcumin dissolution and bioavailability. Drug Dev. Ind. Pharm. 2011, 37, 15–23. [CrossRef] [PubMed]
59. Nepal, P.; Han, H.; Choi, H. Preparation and in vitro-in vivo evaluation of Witepsol H35 based self-nanoemulsifying drug delivery systems (SNEDDS) of coenzyme Q10. Eur. J. Pharm. Sci. 2010, 39, 224–232. [CrossRef] [PubMed]
60. Nazzal, S.; Nutan, M.; Palamakula, A.; Shah, R.; Zaghloul, A.; Khan, M. Optimization of a self-nanoemulsified tablet dosage form of Ubiquinone using response surface methodology: Effect of Formulation Ingredients. Int. J. Pharm. 2002, 240, 103–114. [CrossRef]
61. Norazlinaliza, S.; Mahiran, B.; Basyaruddin, A.; Dzulkefly, K.; Hamidon, B.; Abu, B. Phase behavior, formation and characterization of palm-based esters nanoemulsion formulation containing Ibuprofen. J. Nanomed. Nanotechnol. 2011, 2. [CrossRef]
62. Kulkarni, S.; Nisharani, S.; Govind, M. Development and evaluation of solid self nanoemulsifying formulation of Rosuvastatin Calcium for improved bioavailability. Trop. J. Pharm. Res. 2015, 14, 575–582. [CrossRef]
63. Ashish, D.; Premchand, N.; Pramod, Y. Formulation and in-vitro evaluation of self microemulsifying drug delivery system (SMEDDS) of Furosemide. Pharm. Lett. 2010, 2, 94–106.
64. Pouton, C.; Porter, S. Formulation of lipid-based delivery systems for oral administration: Materials, methods and strategies. Adv. Drug Deliv. Rev. 2008, 60, 625–637. [CrossRef] [PubMed]
65. Ghai, D.; Sinha, V. Nanoemulsions as self-emulsified drug delivery carriers for enhanced permeability of the poorly water-soluble selective 1-adrenoreceptor blocker Talinolol. Nanomedicine 2011, 8, 618–626. [CrossRef] [PubMed]
66. Chun, C.; Linna, H. Improving oral bioavailability of agaricoglycerides by solid lipid-based self-emulsifying drug delivery system. J. Appl. Pharm. Sci. 2011, 1, 195–199.